Clinical Trial Update: Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cetuximab with savolitinib in Ras wild-type colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Savolitinib (savolitinib)

Snippet

Sponsor: Yale University | Conditions: Colorectal Cancer | Phase 1 | Status: WITHDRAWN